QA: SCYNEXIS INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178253_2023_SCYNEXIS_INC.pdf

Logs

Graph

Absolute values for 0001178253, SCYNEXIS INC

  xvar xval
0 AssetsCurrent 79,061,000
1 IntangibleAssetsNetIncludingGoodwill 408,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 8,341,000
4 LiabilitiesCurrent 17,618,000
5 LiabilitiesNoncurrent 2,921,000
6 remainder_Liabilities 64,038,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 62,961,000
9 ResearchAndDevelopmentExpense 27,259,000
10 remainder_Expenses -4,072,000
11 remainder_Revenues 5,091,000
12 remainder_NetIncome 18,248,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 87,810,000
1 Liabilities 84,577,000
2 Expenses 86,148,000
3 Revenues 5,091,000
4 StockholdersEquity 3,233,000
5 NetIncome -62,809,000
6 ComprehensiveNetIncome -62,809,000
7 BaseVar 140,937,000
8 EconomicCapitalRatio -0.664

Edgar->Model Mapping

Feature Distribution

Change over Time